Table 3.
Treatment responses in HCC patients with different PIMET scores.
| Response | PIMET-low (n=61) | PIMET-int (n=166) | PIMET-high (n=77) | P |
|---|---|---|---|---|
| CR | 8 (13.1) | 4 (2.4) | 2 (2.6) | 0.002 |
| PR | 22 (36.1) | 46 (27.7) | 20 (26.0) | 0.376 |
| SD | 19 (31.1) | 87 (52.4) | 26 (33.8) | 0.002 |
| PD | 12 (19.7) | 29 (17.5) | 29 (37.7) | 0.002 |
| ORR | 30 (49.2) | 50 (30.1) | 22 (28.6) | 0.015 |
| DCR | 49 (80.3) | 137 (82.5) | 48 (62.3) | 0.002 |
CR, complete response; DCR, disease control rate; HCC, hepatocellular carcinoma; ORR, objective response rate; PD, progression disease; PR, partial response; SD, stable disease.